首页> 外国专利> REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES.

REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES.

机译:使用包含复合物的I类MHC通过循环病毒特异性细胞毒性T细胞来去除靶细胞。

摘要

Herein is reported a complex comprising as first part an antibody derived part that specifically binds to a target antigen, and as second part a virus-derived peptide linked to a MHC class I protein complex. With the complex as reported herein existing virus-specific circulating cytotoxic T-cells (T-memory-cells or T-effector-cells) of an individual can be directed to cells expressing the target antigen, to which the antibody derived part of the covalent complex specifically binds to, by dressing these cells with a MHC class I complexes mimicking an acute viral infection. Thus, one aspect as reported herein is a complex, characterized in that it comprises one fusion polypeptide that comprises in N- to C-terminal direction either (i) a ß2-microglobulin, and (ii) the extracellular domains a1, a2, and a3 of a class I MHC molecule with a relative frequency of less than 1 %, or (i) a virus- derived peptide, (ii) a ß2-microglobulin, and (iii) the extracellular domains a1, a2, and a3 of a class I MHC molecule with a relative frequency of 1 % or more, and two polypeptide chains, which are linked by one or more disulfide bonds, wherein the first disulfide-linked polypeptide chain comprises in N- to C-terminal direction (i) an immunoglobulin light or heavy chain variable domain, (ii) an immunoglobulin light or heavy chain constant domain, and (iii) an antibody heavy chain hinge region polypeptide, and the second disulfide-linked polypeptide chain comprises an antibody heavy chain hinge region polypeptide, wherein the fusion polypeptide is either covalently bound either to the C-terminus or the N-terminus of one of the disulfide-linked polypeptide chains, or covalently bound to the N-terminus of an antibody variable domain that is the complementary heavy or light chain variable domain to that comprised in the first disulfide-linked polypeptide chain.
机译:本文报道了一种复合物,其包括作为第一部分的与靶抗原特异性结合的抗体衍生部分,以及作为第二部分的与MHC I类蛋白复合物连接的病毒衍生肽。利用本文报道的复合物,可以将个体的现有病毒特异性循环细胞毒性T细胞(T记忆细胞或T效应细胞)导向表达靶抗原的细胞,抗体衍生的共价部分通过用模仿急性病毒感染的MHC I类复合物包被这些细胞,该复合物特异性结合。因此,本文报道的一个方面是复合物,其特征在于它包含一种融合多肽,该融合多肽在N端至C端方向上包含(i)β2-微球蛋白和(ii)细胞外结构域a1,a2和I类MHC分子的相对频率小于1%的a3,或(i)病毒衍生肽,(ii)ß2-微球蛋白,以及(iii)a的细胞外结构域a1,a2和a3相对频率为1%或更高的I类MHC分子,以及两条通过一个或多个二硫键连接的多肽链,其中第一条与二硫键连接的多肽链在N端至C端方向(i)免疫球蛋白轻链或重链可变域,(ii)免疫球蛋白轻链或重链恒定域,和(iii)抗体重链铰链区多肽,第二条二硫键连接的多肽链包含抗体重链铰链区多肽,其中融合多肽是共价结合的或与二硫键连接的多肽链之一的C端或N端共价结合,或与抗体可变域的N端共价结合,该抗体可变域是与第一个包含的互补重链或轻链可变域的互补域二硫键连接的多肽链。

著录项

  • 公开/公告号MX354663B

    专利类型

  • 公开/公告日2018-03-14

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG;

    申请/专利号MX20130014869

  • 发明设计人 HENDRIK KNOETGEN;

    申请日2012-06-19

  • 分类号C07K14/005;C07K14/74;C07K16/28;C07K16/30;C12P21;

  • 国家 MX

  • 入库时间 2022-08-21 12:51:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号